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ABSTRACT 
The aim of this thesis is to investigate the influence of fluorine substitution on the 
second reaction of the sh ikimate pathway catalysed by the enzyme 3-
dehydroquinate synthase. The shikimate pathway is an essential pathway that is 
required for the synthesis of aromatic compounds in bacteria, microbial 
eukaryotes and plants. The enzyme, 3-dehydroquinate synthase, catalyses the 
second step of the shikimate pathway, the conversion of 3-deoxy-D-arahino-
heptulosonate-7-phosphate (DAHP) into 3-dehydroq uinate (DHQ). 
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lt has been reported that when (3S)-3-fluoro DAHP (where fluorine occupies the 
C3 axial position) is treated with the enzyme 3-dehydroquinate synthase, two 
products, the expected (6S)-6-fluorodehydroquinate (5) and its CI epimer, (6S)-6-
fluoro- l-epideydroquinate (6) are fo1med in a ratio of 2 : I. 
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The CI epimer of 3-dehydroquinate was reported to be formed from the natural 
substrate DAHP in a solution reaction, but not in the enzyme catalysed reaction. 
Therefore, it has been suggested that fluorine substitution at the axial position on 
C3 stabilises the fluoroenolpyranose intermediate allowing the intermediate to 
dissociate from the enzyme and cyclise to complete the formation of (6S)-6-
fluoro-1-epideydroquinate free in solution. The results reported in this thesis are 
from an investigation carried out to understand further the influence of fluorine 
orientation on the stereochemical outcome of the products in the dehydroquinate 
synthase reaction. 
(3S)-3-Fluoro DAHP was synthesised in large amounts using both chemical and 
enzymatic synthesis. This was achieved by treating the isomers of 3-fluoro 
phosphoenolpyruvate and D-erythrose 4-phosphate with DAHP synthase, the first 
enzyme of the shikimate pathway. The erythrose 4-phosphate was prepared by 
lead tetraacetate oxidation of D-glucose 6-phosphate. The isomers of 3-fluoro 
phosphoenolpyruvate were prepared from 3-bromo, 3-fluoropyruvic acid by the 
Perkow reaction. Then (3S)-3-fluoro DAHP was purified by anion exchange 
chromatography. The chemical synthesis of erythrose 4-phosphate and the 
isomers of 3-fluoro phosphoenolpyruvate and the enzymatic synthesis of (3S)-3-
fluoro DAHP and its purification are discussed in Chapter Two. 
A recombinant Escherichia coli strain (pJB 14) was used to over-express the 
enzyme dehydroquinate synthase, and partial purification of the enzyme was 
achieved by anion exchange chromatography. Chapter Three describes the 
production and purification of the enzyme 3-dehydroquinate synthase. 
IV 
Purified (3S)-3-fluoro DAHP was treated with the £. coli enzyme 3-
dehydroquinate synthase. Fo,mation of both (6S)-6-fluorodehydroquinate and its 
C 1 epimer was observed. The reaction was followed at different pH and 
temperature values. The ratio of products produced in the enzyme-catalysed 
reaction was monitored by 19F NMR spectroscopy. No significant change in the 
ratios was observed with the different conditions employed. The results from 
these experiments are discussed in Chapter Four. Our results are consistent with 
the hypothesis that the fluoroenolpyranose intermediate is released to the solution, 
where it cyclises without the constraint of an enzymatic template. To test this 
hypothesis unequivocally, fu11her investigations are required and these are 
discussed in Future Directions. 
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1 Introduction 
1.1 The Shikimate Pathway 
Organisms differ markedly in their ability to carry out the chemical reactions 
involved in the biosynthesis of the amino acids, which are the constituents of 
proteins and peptides. Amongst the amino acids, which cannot be produced by 'de 
novo' synthesis in animals are the three aromatic amino acids L-phenylalanine, L-
tyrosine and L-tryptophan. In plants and microorganisms the shikimate pathway 
(Figure 1.1) is responsible for the production of these aromatic amino acids, and 
other primary and secondary aromatic metabolites from ubiquinone to morphine. In 
a sequence of seven metabolic steps, phosphoenolpyruvate and erythrose 4-
phosphate are converted to chorismate, the precursor of the aromatic amino acids 
and many aromatic metabolites such as anthranilate, para-hydroxybenzoate, and 
para-aminobenzoate. 1 This pathway is found in plants (where it can account for 20-
30% of the carbon flux) , fungi, protozoa, bacteria and recently been detected in 
several apicomplexan parasites.21 This pathway is the target of the very successful 
broad-spectrum herbicide, glyphosate, the active ingredient of RoundupR which 
inhibits 5-enolpyruvylshikimate-3-phosphate synthase, the sixth enzyme of the 
I 10 pat1way. 
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Figure 1.1 The Shikimate Pathway? 1 
2 
2 
OH 
3-deh ydroquin a te 
OH 
chorismate 
The second enzyme of the pathway, 3-dehydroquinate synthase (formerly named as 
7-phospho-3-deox y-D-arahino-heptulosonate phosphate lyase) catalyses the 
conversion of 3-deoxy-D-arahino-heptulosonate 7-phosphate (1 , DAHP) into 3-
dehydroquinate (2, DHQ), the first carbocyclic metabolite in the pathway (Figure 
1.1). 
As a key step in the shikimate pathway, DHQ synthase is a potential target for new 
antifungal and antibacterial drugs. The suitability of DHQ synthase as a target is 
supported by the finding that inactivation of DHQ synthase in Salmonella 
typhimurium results in a strain attenuated for virulence in BALB/c mice. 1x Similar 
effects on virulence may occur if appropriate chemical compounds could inhibit 
DHQ synthase. Inhibitors of DHQ synthase activity may therefore have therapeutic 
value. The rational development of DHQ synthase inhibitors demands a detailed 
characterisation of its catalytic mechanism. Detailed studies have already revealed 
much of the catalytic mechanism and are outlined in Section 1.3. 
1.2 The aim of the studies 
DAHP is the natural substrate for 3-dehydroquinate synthase. The isomers (3S)-
and (3R)-3-fluoro DAHP (3, 4) have also been shown to act as substrates for 
Escherichia coli 3-dehydroquinate synthase.2x It has been reported that the enzyme 
processes these isomers differently.2x With the (3R)-isomer (4, fluorine m 
equatorial position), the expected product (6R)-6-fluorodehydroquinate (7) is 
formed, but with the (3S)-isomer (3, fluorine in axial position), two products, the 
expected (6S)-6-fluorodehydroquinate (5) and (6S)- 6-fluoro-1-epidehydroquinate 
(6) are formed in a 2 : I ratio. This observation raises the question: why is there a 
difference in the outcome of the reaction of (3S)-3-fluoro DAHP and its (3R)-
isomer in the reaction catalysed by DHQ synthase? 
The objectives of the present study were to investigate the influence of the fluorine 
orientation on the stereochemical outcome of the process and determine the role of 
the enzyme DHQ synthase in guiding the formation of the correct epimeric product. 
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1.3 The mechanism of 3-dehydroquinate synthase 
1.3.1 Proposed mechanism for the conversion of DAHP into 3-dehydroquinate 
£. coli DHQ synthase is a monomeric protein of 362 amino acid residues that 
requires, for catalytic activity, the presence of both a divalent metal cation and 
NAO+, a redox cofactor.22 Although the enzyme requires NAO+ for catalytic 
activity no overall oxidation occurs during the conversion. Sprinson33 and 
colleagues proposed an interesting and ingenious mechanistic pathway for the 
conversion of DAHP to 3-dehydroquinate (Figure 1.2). A similar mechanism was 
later found for the 2-deoxy-scyllo-inosose synthase of Streptomyces fradiae, an 
enzyme involved in antibiotic biosynthesis.36 
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Figure 1.2 Proposed mechanism for the conversion of DAHP into 3-
dehydroquinate. 
In the first step of the mechanism, the substrate is oxidised at CS of DAHP and 
NAD+ is reduced. This involves hydride transfer from CS of DAHP to the NAD+ 
nicotinamide moiety. This increases the acidity of C6 hydrogen of DAHP, which 
facilitates the ~-elimination of the phosphate group. The second step is ~-
elimination of the phosphate group. During phosphate elimination, a proton is 
removed from C6 of DAHP. In the third step, the CS ketone of intermediate (ii) is 
reduced by NADH. This is the reversal of the first step, with hydride ion from 
NADH being transferred back to CS of the substrate, generating the enolpyranose 
(iii) with unchanged stereochemistry of the CS hydroxyl group. This enolpyranose 
is a key intermediate in the overall transformation. The final two steps of the 
reaction are ring opening followed by an intramolecular aldol condensation. The 
ring opening is followed by a rotation about the CS - C6 bond and an 
intramolecular aldol condensation to form the carbocycle 3-dehydroquinate. 
5 
The complexity of the mechanism has raised the question of how oxidation and 
reduction, phosphate cleavage, ring opening and aldol ring closure reactions could 
be catalysed by a simple monomeric enzyme. Results of studies by Knowles22 and 
Bender et a/.4· 5 and Bartlett et al.2- 3 however, validated the mechanism and 
appeared to reduce the role of the enzyme to little more than that of an 
oxidoreductase. 
1.3.2 Previous work done on the validation of the proposed mechanism 
The difficulty in studying the mechanism of DHQ synthase with the natural 
substrate is that the reaction appears to be irreversible, and the enzyme-bound 
intermediates cannot be examined under equilibrium conditions. However substrate 
analogues have long been considered as valuable tools for probing enzyme 
h . d b . . K I 4 5 22 d h. mec arnsms an enzyme su strate mteract1ons. now es · ' an 1s group 
synthesised different substrate analogues of DAHP that can partially undergo the 
various stages along the reaction pathway illustrated in Figure 1.2. Evidence for the 
involvement of NAD+ in the catalytic pathway comes from the production of a 
species absorbing at 340 nm (where NADH absorbs) when the 
carbahomophosphonate analogue of DAHP (8, Figure 1.3) was incubated with the 
enzyme.4 This analogue cannot undergo phosphate elimination and therefore can 
only undergo the first oxidation step of the catalytic mechanism. 
OH 
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+ NAD OH NADH 
Figure 1.3 Action of DHQ synthase on carbahomophosphonate. 
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Figure 1.4 The cyclic and acyclic fo1ms of DAHP. 
It has been noted that, DAHP exists in equilibrium between cyclic and acyclic 
forms (Figure 1.4) and the cyclic form is found to be predominant.2~ The cyclic 
form of DAHP was proposed to be the substrate for DHQ synthase, when it was 
shown that the cyclic 2-deoxy analogue of DAHP (9, Figure 1.5) was accepted as a 
substrate by dehydroquinate synthase, but the acyclic 2-deoxy-substrate analogue 
was not.4 Although 9 was accepted as a substrate for DHQ synthase, it cannot 
undergo the whole sequence of reactions illustrated in Figure 1.2. Without the 
hydroxyl group at C2, this analogue cannot undergo the ring opening from 
pyranose to open-chain ketose. When the cyclic 2-deoxy substrate analogue 9 
was incubated with the enzyme, inorganic phosphate and the enol ether 10 were 
produced catalytically. This result shows that the enzyme will release intermediate 
analogues into solution, even those that have not undergone the last two suggested 
steps in the mechanism (Figure 1.2) and establishes the fact that ring opening does 
not occur until after the reduction step. 
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-
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Figure 1.5 Action of DHQ synthase on 2-deoxy DAHP. 
7 
Stereospecifically labelled [7S - 2H]-2-deoxy DAHP was used to show that the 
elimination proceeds with syn stereochemistry.37 It was proposed that syn 
elimination of phosphate was most likely to proceed through an enolate 
intermediate by a stepwise EI cb mechanism. To probe this the substrate analogues 
8, 11, 12 and 13, were incubated with the enzyme in D20 to examine if there was 
exchange of the C6 proton. Very slow exchange was observed for the 
carbahomophosphonate (8), but not the phosphonate (11) and similarly slow 
exchange was observed for the cis-vinyl homophosphonate (12), but not the trans-
vinyl homophosphonate (13). This finding led to the suggestion that the phosphate 
dianion of the substrate can act as its own base to abstract the C6 proton. 
OH 
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8 
12 
+ NAD 
P03
2 
OH 11 
OH 13 
From the studies with these substrate analogues it was established that the true 
substrate for the enzyme is apparently the pyranose or cyclic form of the DAHP and 
the ~-elimination proceeds with syn stereochemistry from the cyclic a-pyranose 
form of the substrate. More information concerning the possible transition state for 
the aldol condensation was derived by considering the overall stereochemistry for 
the syn elimination. As already noted by Srinivasan et al. 33 during conversion of 
DAHP to DHQ, the C7 configuration of DAHP undergoes inversion. The two 
possible transition states that satisfy both these observations (syn elimination, and 
overall inversion) are a chair-like transition state and a hoat-like transition state. 
However with the consideration of steric effects and of minimal motion the most 
favoured transition state is a chair-like transition state for the ring closure reaction. 
8 
It can be obtained from the a pyranose form of DAHP by a 180° rotation about the 
bond between C5 and C6. This also seems likely since the preferred conformation 
for DHQ is a chair structure. The C6 to C7 double bond adds to the re face of the 
carbonyl bond at C2 from above. The overall picture for the final two steps of the 
mechanism is shown in Figure 1 .6. 
Figure 1.6 The overall picture for the final two steps of the DHQ synthase 
reaction. 
To study the involvement of the enzyme in the final two steps of the reaction, 
Bartlett et al.3 synthes ised the o-nitrobenzyl protected enolpyranose intermediate 14 
and showed that following the photochemical removal of the o-nitrobenzyl 
protecting group from 14, the enolpyranose was completely converted into 3-
dehydroquinate (2) in the absence of the enzyme (Figure 1.7). Studies with a 
deuterium-labelled form of precursor 14 were consistent with the cycl isation 
proceeding through the same chair-like transition state as had been suggested for 
the enzyme-catalysed aldol step.3 These findings were taken to imply that the 
enzyme does not play any role in the ring opening and cyclisation steps and that 
enolpyranose is the true product of the DHQ synthase reaction. This result is also 
9 
consistent with the Knowles4 earlier studies which showed that the enzyme will 
release intermediate analogues into solution, even those that have not undergone the 
last two suggested steps in the mechanism. With the consideration of Bartlett' s 
work on the final two steps of the proposed mechanism and his own work with the 
substrate analogues, Knowles described this enzyme as a "banal dehydrogenase" 
responsible only for the formation of the enolpyranose and stated that the enzyme is 
only actively involved in the oxidation and reduction steps and other steps take 
place spontaneously.22 However. later studies have revealed the involvement of the 
enzyme in some of the other steps of the mechanism as described in the next 
section. 
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Figure 1.7 Formation of 3-dehydroquinate from the o-nitrobenzyl protected 
enol pyranose. 
IO 
1.3.3 The studies that support the involvement of the enzyme in the phosphate 
elimination step and the final two steps of the mechanism 
Montchamp and Frost26 synthesised d iffe rent cyclohexenyl (15, 16, 17 and 18) and 
cyc lohexylid ine (23, 24) inhi bitors of DHQ synthase and measured their inhibition 
constants. When these values were compared with the inhibition constants of the 
correspond ing cyclohexyl analogues (19, 20, 21 and 22), an increased inhibition for 
cyclohexenyl and cyclohexylid ine analogues relative to the corresponding 
cyclohexyl analogues was observed with one exception. F rom the impact of 
strategically placed o lefinic residues in inhibito rs on active site binding, they 
suggested that the acti ve site of DHQ synthase might not merely be a spectator 
during e li m ination of inorganic phosphate from intermediate i (Figure 1.2). It has 
been proposed that the ac ti ve site might accelerate the e limination of inorganic 
phosphate by restricting the conformational flex ibility of the phosphorylmethyl 
group of inte1mediate i or might stabili se the E lcb inte1mediate or El cb-like 
transition state.26 
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R = P0,1-12 
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24 R =CH2P031-12 
Bartle tt2 re investigated the non-enzymatic gene ration of 3-dehydroquinate from o-
nitrobenzyl protected enolpyranose intermediate 14. From this re investigation, it 
was found that the reaction of the enolpyranose was not entirely stereospecific with 
between 2.5 and 4 % of 1-epidehydroquinate 25 also being formed (Figure 1.8). By 
contrast the enzymatic reaction is entirely specific. Addition of excess enzyme did 
not effect the ratio of 3-dehydroquinate to 1-epidehydroquinate formed, suggesting 
11 
that the rate of spontaneous rearrangement of the enolpyranose is faster than the 
uptake by the enzyme. Bartlett et a/. 2 proposed that the 1-epidehydroquinate was 
fo1med from attack of the enolate on the si face of the carbonyl in a solution 
reaction that passes through a similar chair-like transition state as that proposed in 
the reaction to form 3-dehydroquinate. 1-Epidehydroquinate is not observed in the 
enzymatic reaction. Therefore, Bartlett er a!.2 stated that the enzyme is acting as a 
template in guiding the conversion of enolpyranose to 3-dehydroquinate with the 
correct stereochemistry. 
2 
3-dehydroquinate 
o" H 
H 
-o,c f~OH 
0 H'':\ ~ 
B OH HO 0 
25 
1-epidehydroquinate 
Figure 1.8 Formation of 3-dehydroquinate and 1-epidehydroquinate from 
the o-nitrobenzyl protected enolpyranose. 
12 
The crystal structure of the DHQ synthase domain of the AROM protein from 
Aspergillus nidulans reveals that the enzyme may catalyse the phosphate 
elimination by providing a phosphate binding pocket, thus forcing the phosphate 
oxygens into a position where it can remove the proton from C6. 11 It also reveals, 
that the carboxylate group of DAHP is held by the active sites of the enzyme and it 
is not possible for the enolate to attack the other face of the keto group for the 
formation of the CI epimer of 3-dehydroquinate on the enzyme and supports the 
finding of Bartlett et a/. 2 that the enzyme is acting as a template for the formation 
of the correct product. 11 On the basi s of computational molecular superimposition 
studies with carbaphosphonate Piehler et al. 29 also suggest the existence of an 
enzyme active side residue, which enables DHQ synthase to play an active catalytic 
role during intramolecular aldol condensation. The question still remains, however, 
whether or not the enzyme is actively catalysing the conversion of DAHP into 3-
dehydroquinate. 
1.4 Studies with the isomers of 3-fluoro DAHP 
The isomers of 3-fluoro DAHP were synthesised by Parker2x as part of the studies 
to prepare 6-fluoroshikimates enzymatically to study their antibiotic properties. 
During these studies it was observed that when (3R)-3-fluoro DAHP (4) generated 
by DAHP synthase was treated with the enzyme DHQ synthase the (3R)-isomer 
was rapidly conve1ted to the expected (6R)-6-fluorodehydroquinate (7, Figure 1.9). 
However the (3S)-3-fluoro DAHP (3) was slowly converted to a mixture of (6S)-6-
fluorodehydroquinate (5) and (6S)-6-fluoro- l-epidehydroquinate (6). This was the 
first time the formation of epimer had been observed during enzymatic reaction. In 
(3R)-3-fluoro DAHP the fluorine atom is in the down or equatorial position 
whereas in (3S)-3-fluoro DAHP the fluorine occupies the up or axial position. 
These compounds differ from the natural substrate only by the substitution of 
hydrogen for fluorine and from each other solely by the orientation of the fluorine. 
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Figure 1.9 Treatment of 3-fluoro DAHP with DHQ synthase. 
Two products can be formed from the DHQ synthase reaction due to attack of 
·ihe. enolate on the two different faces of the carbonyl in the final cyclisation step 
(Figure 1.10). When the non fluorinated enolpyranose was generated in solution 
format ion of both 3-dehydroquinate and the epimer was observed, while in the 
enzymatic reaction formation of 3-dehydroquinate only is detected. The generation 
of two products, the expected (6S)-6-fluorodehydroquinate and the unexpected 
(6S)-6-fluoro- I epidehydroquinate, when the substrate for DHQ synthase is (3S)-3-
fluoro DAHP, suggests that the aldol ring c losure may occur non-enzymatically. 
Already Bartlett et a/.2 had shown that the enzyme is acting as a template fo r the 
formation of the product with correct stereochemistry. The crystal structure of the 
DHQ synthase from A. nidulans also suggests that there is interaction between the 
active sites of the enzyme and the carboxylate group of DAHP, in a manner that 
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would hold the keto functionality so that attack on it would give rise to only one 
product. Therefore it seems unlike ly that the epimer is produced on the enzyme. 
There are two possible scenarios that could account for the formation of two 
products from (3S)-3-fl uoro DAHP. It is possible that the fluoroenolpyranose 
intermediate is released into the solution completely or that it is released partially. 
If the fluoroenolpyranose intermediate is released completely into solution it may 
cyclise giving both the correct expected product and the unexpected epimer. In the 
solution reaction the ring opened fluoroenolpyranose intermediate has the 
conformational freedom to produce the unexpected epimer. The other possibility is 
that fluoroenolpyranose intermediate may leak partially into solution and the 
conformational freedom of the intermediate can lead to the exclusive formation of 
the unexpected epimer. Therefore, it is possible that the expected product is formed 
on the enzyme, and the unexpected epimer is generated off the enzyme. To clarify 
these results, an understanding of the trans ition states involved in the final 
cyclisation is necessary. 
There are two chair and two hoat transition states for the reaction of the enolate to 
3-dehydroquinate and correspondingly four trans ition states for reaction to the CI 
epimer of dehydroquinate (Figure 1.10). As outlined in section 1.3.2, the si face of 
the enolate attacks the re face of carbonyl in the enzymatic cyclisation g iving 3-
dehydroquinate. Only the chair A and hoot B transi tion states are consistent with 
this, however the chair transi tion state has been considered to be the most likely 
and the hoat transition state has been paid little attention. For non-enzymatic 
generation of 3-dehydroquinate, labelling studies have also shown that either chair 
A or hoot B transition state is involved.3 For formation of 1-epidehydroquinate 
Bartlett et a!.'2 suggested that a chair transition state is involved in which the si face 
of enolate attacks the si face of the carbonyl. However no labelling studies have 
been carried out to support this suggestion, so the face of the enolate involved in the 
formation of 1-epidehydroquinate is unknown. 
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For the reaction of (3S)-3-fluoro DAHP. and for the non-enzymatic generation of 1-
epidehydroquinate from DAHP, all the possible transition states need to be 
considered, as no labelling studies have been carried out to detennine which face of 
the enolate is involved. According to the Felkin - Anh model, 14 transition states for 
the internal aldol reaction would be expected to be most favoured when the fluorine 
is orthogonal to the carbonyl bond and at 180° to the direction of attack by enolate. 
Applying this argument hoat F and chair G would be expected to be favoured 
among the four transition states E to H for epimer fonnation. Of the four transition 
states leading to the formation of (6S)-6-fluorodehydroquinate, hoot B and chair C 
would be expected to be more favoured. Chair A, the favoured transition state 
confonnation for the enzymatic cyclisation, would be disfavoured. 
Fluorine atoms adjacent to hemiketals and hydrates are more stable than the 
corresponding ketones.27 Therefore fluorine substitution may provide stability on 
the fluoroenolpyranose intermediate. This may lead to the intermediate dissociating 
from the enzyme completely or partially and cyclising free in solution. 
For the (3R)-isomer, it is difficult to predict, whether the fluoroenolpyranose 
intermediate comes off the enzyme or not. The fluorine occupies a position 
orthogonal to the carbonyl bond and anti to the direction of attack by the enolate in 
chair transition state A. Therefore, the reaction might be expected to go rapidly 
with exclusive formation of the correct expected product. 
Therefore, it has been hypothesised that axial fluorine stabilises the enolpyranose 
intermediate long enough for it to dissociate from the enzyme completely or 
partially and once in solution the fluoroenolpyranose intennediate cyclises without 
the constraint of the enzymatic template. Off the enzyme, the influence of the 
fluorine gives rise to the unexpected epimer.~7 
16 
A 
C 
OH 
,,,,•· 
R, 
B 
R1 OH 0-
- H 
CO2 0 OH 
I) 
R 1 = R2 = H, dehydroquinate 
R1 = F, R2 = H, (6S)-6-fluorodehydroquinate 
R1 = H, R2 = F, (6R)-6-fluorodehydroquinate 
R1 0 H 
R2\\'' OH 
0 co, -
- 0 
E F 
., ~ 
O CO2 OH H 
G H 
R 1 = R2 = H, 1-epidehydroquinate 
R1 =F,R2 =H, 
(6S)-6-fluoro-1-epidehydroquinate 
Figure 1.10 Poss ible transition states for the formation of epimers. 
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1.5 Outline of the project 
To test this hypothesis and gain more infom1ation about the final two steps of the 
mechanism, as a preliminary investigation, it was decided to examine the 
interaction of (3S)-3-fluoro DAHP with DHQ synthase at different reaction 
conditions, such as temperature and pH by using 19F NMR spectroscopy. A change 
in the reaction conditions may provide information as to whether the reaction is 
occurring on the enzyme or off the enzyme. If one product is fonned on the enzyme 
and the other is formed off the enzyme, changing the reaction conditions may lead 
to significant changes in the ratio of products formed. Therefore it was decided to 
monitor the ratio of products formed. There are other approaches, which can also be 
used to test this hypothesis and are explained in future directions. 
In these studies a considerable amount of (3S)-3-fluoro DAHP was synthesised by 
the DAHP synthase catalysed reaction of 0-erythrose 4-phosphate and the isomers 
of 3-fluoro PEP. Purification of (3S)-3-fluoro DAHP was achieved by an ion 
exchange chromatography. The preparation and purification of (3S)-3-fluoro DAHP 
are discussed in Chapter 2. Erythrose 4-phosphate was prepared by the method of 
Simpson et al. 32 (Z)- and (£)-3-Fluoro PEP was synthesised b~~rkow reaction. 
Their chemical syntheses are explained in Chapter Two. It has been recently 
reported that£. coli DAHP synthase (phe) catalyses the aldol type condensation of 
PEP with the five carbon analogues o-arabinose 5-phosphate, D-ribose 5-
phosphate, and 2-deoxy-o-ribose 5-phosphate.31 Since 3-fluoro PEP was 
synthesised for the production of (3S)-3-fluoro DAHP, it was decided to test, 
whether, £. coli DAHP synthase (phe) catalyses the aldol type condensation of 3-
fluoro PEP with the five carbon analogues 0-arabinose 5-phosphate, and 0-ribose 
5-phosphate. From these studies it appears that the enzyme also catalyses these 
reactions. The findings from this study are discussed in Chapter Two. 
E. coli strain (pJB 14) was used in the expression of the enzyme DHQ synthase. 
The cell growth and purification of the enzyme DHQ synthase were carried out 
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according to Frost et a/. 16, with some modifications to the purification protocol. The 
production and purification of the enzyme are discussed in Chapter Three. 
Chapter Four discusses the interaction of the enzyme DHQ synthase with (3S)-3-
tluoro DAHP at different temperature and pH values. The ratio of products 
produced in the enzyme-catalysed reaction was monitored by 19F NMR 
spectroscopy. No significant change in the ratio of products formed was observed. 
These observations are consistent with the hypothesis that the tluoroenolpyranose 
intermediate is released to the solution, where it cyclises freely to give two 
products. To further test this hypothesis other investigations are necessary and these 
are discussed in the future directions. 
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